Ksp-cadherin in Kidney Development and Cancer
Author Information
Author(s): Thedieck C, Kuczyk M, Klingel K, Steiert I, Müller C A, Klein G
Primary Institution: University Medical Clinic, Tübingen, Germany
Hypothesis
The expression of Ksp-cadherin is downregulated in renal cell carcinoma (RCC).
Conclusion
Ksp-cadherin expression is lost in RCC, suggesting its role in tumor suppression.
Supporting Evidence
- Ksp-cadherin is exclusively expressed in epithelial cells of the adult kidney.
- Ksp-cadherin expression is completely abrogated in RCC tissues.
- mRNA synthesis of Ksp-cadherin is detectable in RCC tissues but at reduced levels.
- The loss of Ksp-cadherin protein was only observed in the malignant part of the tumor kidneys.
Takeaway
Ksp-cadherin is a special protein found in the kidneys, and it disappears in kidney cancer, which might help doctors understand how to fight the disease.
Methodology
The study used RT-PCR, immunohistochemistry, and Western blot analysis to assess Ksp-cadherin expression in RCC cell lines and tissues.
Limitations
The study primarily focused on a limited number of RCC cell lines and tissues.
Participant Demographics
13 RCC patients and 3 normal kidney samples.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website